Such a mechanism is also known for increased angiogenesis in cancer by shed SDC-1 with binding to pro-angiogenic factors such as VEGF, FGF2, insulin-like growth factor 1 receptor—IGFR1 and presenting these growth factors to their respective receptors [44]. The gene discussed is FGF2; the disease is cancer.